PRODUCT DETAILS

About Victoza Solution for Injection

LIRAGLUTIDE belongs to the class of anti-diabetic drugs, primarily used to treat type 2 diabetes mellitus in the children above 10 years and adult. Diabetes mellitus is a metabolic disease that causes high blood sugar levels. Type 2 diabetes occurs when a hormone released by the pancreas to lower blood glucose called 'insulin' is secreted but unable to get utilized by our body's cell to produce energy.  

Uses of Victoza Solution for Injection

Type 2 Diabetes mellitus 

Medicinal Benefits of Victoza Solution for Injection

LIRAGLUTIDE treats type 2 diabetes mellitus and contains ‘Liraglutide’. It is a recombinant DNA (rDNA) that mimics the action of a natural hormone called Incretin (metabolic hormone, which stimulates a decrease in blood glucose levels). It works by increasing insulin release from the pancreas during high blood sugar levels (after meal) and decreases the amount of sugar the liver makes. LIRAGLUTIDE may be advised with or without other medications along with diet and exercise to control blood sugar levels. 

Directions for Use

LIRAGLUTIDE is administered in the form of injection under the skin. Your doctor prescribes the dosage based on your disease condition and tolerance. Your doctor may start the course with a low dose and gradually maintain an effective dose to achieve the required blood glucose control. Injection pen: Use LIRAGLUTIDE injection solution only if it is clear, colourless, and contains no particles. Inject LIRAGLUTIDE subcutaneously (under the skin) in the abdomen, thigh or upper arm. You can take LIRAGLUTIDE with or without a meal. Take LIRAGLUTIDE preferably with a meal, since it lowers the blood sugar levels and may cause gastrointestinal side effects. Store the LIRAGLUTIDE pen in a refrigerator or at room temperature and use within 30 days. Do not freeze LIRAGLUTIDE.

Side Effects of Victoza Solution for Injection

• Nausea
• Vomiting
• Diarrhoea
• Decreased appetite
• Stomach upset
• Constipation
• Headache
• Feeling tired
• Rash
  • Dizziness 

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

Brief your medical history if you have any heart, kidney or liver diseases, pancreatitis (inflammation of the pancreas), stomach disorders like gastroparesis (delayed gastric emptying), high cholesterol levels, gallbladder problems, and depression before starting LIRAGLUTIDE. LIRAGLUTIDE is contraindicated in patients with multiple endocrine neoplasia type 2 (tumours in thyroid and parathyroid glands) and personal or family history of thyroid cancer. Do not concurrently use LIRAGLUTIDE with prandial insulin (mealtime insulin). If you are also using insulin, take LIRAGLUTIDE and insulin injections separately. Please do not mix them. You can inject both injections in the same body region, but the injection sites should not be next to each other. Do not share an injection pen, cartridge, or syringe with another person, even if the needle is changed. It is advised to limit your alcohol intake while using LIRAGLUTIDE to avoid low blood sugar levels further. Pregnant and breastfeeding women should consult their doctor before starting this medication. LIRAGLUTIDE is advised to be only used in children above ten years of age and adults. 

Drug Interactions

Drug-Drug Interaction:

LIRAGLUTIDE may interact with other anti-diabetic medicines (insulin glargine, insulin degludec), hormones (levothyroxine), corticosteroids (prednisone), psychiatric medicines (olanzapine), antibiotics (ciprofloxacin), high blood pressure medicines (propranolol, metoprolol), and glaucoma eye drops (timolol). 

Drug-Disease Interaction:

Tell your doctor before taking LIRAGLUTIDE if you have a medical history of allergic reactions to medicines, heart, kidney or liver diseases, pancreatitis (inflammation of the pancreas), stomach disorders like gastroparesis (delayed gastric emptying), high cholesterol levels, gallbladder problems, and depression. LIRAGLUTIDE is contraindicated in patients with multiple endocrine neoplasia type 2 (tumours in thyroid and parathyroid glands) and personal or family history of thyroid cancer.

Safety Advice

ALCOHOL

• It is advised to limit alcohol intake since it may worsen the side effects and increase the risk of developing low blood sugar levels.

PREGNANCY

• Animal studies of LIRAGLUTIDE showed harmful effects on the foetus. It is advised to use LIRAGLUTIDE in pregnancy only if the benefit outweighs the risk. Please consult your doctor before starting LIRAGLUTIDE if you are pregnant or planning to conceive.

BREAST FEEDING

• There is no sufficient data on how LIRAGLUTIDE affects breastfeeding. It is safe to seek medical advice before you start LIRAGLUTIDE if you are lactating.

DRIVING

• Your driving may be affected if your blood sugar levels are too high or too low. Do not drive or operate machinery if you also experience blurred vision, dizziness or drowsiness due to extremely low or high blood sugar.

LIVER

• Let your doctor know if you have any history of liver diseases or hepatic impairment when prescribed LIRAGLUTIDE.

KIDNEY

• Let your doctor know if you have any history of kidney diseases when you are prescribed LIRAGLUTIDE.